Trial Profile
Effect of Apixaban on the Pharmacokinetics of Digoxin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2014
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Digoxin
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 17 Oct 2014 New trial record